Sustained vessel normalization with the blockade of angiopoeitin-2 (ANG2) along with VEGF inhibition has been reported as a more effective strategy in increasing pericyte coverage and improving functionality of tumor vasculature (34). Here, VEGFA is linked to neoplasm.